开立医疗
(300633)
| 流通市值：121.16亿 | | | 总市值：121.16亿 |
| 流通股本：4.33亿 | | | 总股本：4.33亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,398,196,592.81 | 1,012,691,317.35 | 479,333,865.45 | 2,120,251,604.73 |
| 营业收入 | 1,398,196,592.81 | 1,012,691,317.35 | 479,333,865.45 | 2,120,251,604.73 |
| 二、营业总成本 | 1,351,044,835.32 | 872,746,020.51 | 394,005,611.99 | 1,665,265,681.56 |
| 营业成本 | 467,203,720.24 | 329,854,804.92 | 146,687,089.41 | 648,554,377.98 |
| 税金及附加 | 13,164,362.01 | 9,605,480.72 | 4,343,980.51 | 24,436,134.44 |
| 销售费用 | 458,783,435.33 | 287,288,362.53 | 122,907,237.61 | 524,364,856.42 |
| 管理费用 | 100,941,379.2 | 62,817,254.23 | 34,545,545.65 | 128,328,978.83 |
| 研发费用 | 338,307,834.78 | 212,179,984.55 | 101,637,595.01 | 384,256,460.57 |
| 财务费用 | -27,355,896.24 | -28,999,866.44 | -16,115,836.2 | -44,675,126.68 |
| 其中:利息费用 | 4,636,853.16 | 2,405,886.71 | 841,323.5 | 5,053,850.45 |
| 其中:利息收入 | 36,827,182.9 | 28,191,946.34 | 17,014,603.44 | 46,665,187.01 |
| 加:公允价值变动收益 | 3,907,207.41 | 2,465,494.69 | 113,973.75 | -175,542.46 |
| 加:投资收益 | -2,487,958.79 | -2,939,022.18 | -1,950,941.6 | -12,667,407.84 |
| 资产处置收益 | 11,857.35 | - | - | 20,353.98 |
| 资产减值损失(新) | -10,117,222.04 | -10,117,222.04 | - | -51,118,951.1 |
| 信用减值损失(新) | -8,437,016.82 | -15,350,738.79 | -7,656,364.29 | -14,336,403.56 |
| 其他收益 | 85,674,244.83 | 62,805,425.56 | 35,198,992.96 | 98,106,549.83 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 115,702,869.43 | 176,809,234.08 | 111,033,914.28 | 474,814,522.02 |
| 加:营业外收入 | 766,289.65 | 636,881.84 | 600,311.26 | 218,623.73 |
| 减:营业外支出 | 877,200.3 | 814,360.24 | 97,158.16 | 1,202,132.63 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 115,591,958.78 | 176,631,755.68 | 111,537,067.38 | 473,831,013.12 |
| 减:所得税费用 | 6,606,159.31 | 6,058,405.32 | 11,346,239.75 | 19,393,538.51 |
| 六、净利润 | 108,985,799.47 | 170,573,350.36 | 100,190,827.63 | 454,437,474.61 |
| 持续经营净利润 | 108,985,799.47 | 170,573,350.36 | 100,190,827.63 | 454,437,474.61 |
| 归属于母公司股东的净利润 | 108,985,799.47 | 170,573,350.36 | 100,190,827.63 | 454,437,474.61 |
| (一)基本每股收益 | 0.25 | 0.4 | 0.23 | 1.06 |
| (二)稀释每股收益 | 0.25 | 0.39 | 0.23 | 1.05 |
| 八、其他综合收益 | 2,331,694.88 | -291,499.8 | 1,662,272.04 | 5,208,154.07 |
| 归属于母公司股东的其他综合收益 | 2,331,694.88 | -291,499.8 | 1,662,272.04 | 5,208,154.07 |
| 九、综合收益总额 | 111,317,494.35 | 170,281,850.56 | 101,853,099.67 | 459,645,628.68 |
| 归属于母公司股东的综合收益总额 | 111,317,494.35 | 170,281,850.56 | 101,853,099.67 | 459,645,628.68 |
| 公告日期 | 2024-10-26 | 2024-08-29 | 2024-04-27 | 2024-04-12 |
| 审计意见(境内) | | | | 标准无保留意见 |